Apart from its clinical use in imaging, ultrasound has been thoroughly investigated as a tool
to enhance drug delivery in a wide variety of applications. Therapeutic ultrasound, as such …

Bubbles in liquids, soft and squeezy objects made of gas and vapour, yet so strong as to
destroy any material and so mysterious as at times turning into tiny light bulbs, are the topic …

Ultrasound‐induced bubble activity (cavitation) has been recently shown to actively
transport and improve the distribution of therapeutic agents in tumors. However, existing …

The development of microbubble contrast agents has broadened the scope of medical
ultrasound imaging. Along with dedicated imaging techniques, these agents provide …

Microfluidic technologies have a unique ability to control more precisely and effectively on
two-phase flow systems in comparison with macro systems. Controlling the size of the …

Acoustic emission was monitored during focused ultrasound exposures in conjunction with
an ultrasound contrast agent (Optison®) in order to determine if cavitation activity is …

Zero-thickness interface models are developed to describe the encapsulation of
microbubble contrast agents. Two different rheological models of the interface, Newtonian …

Microbubbles are used as ultrasonic contrast agents that enhance the ultrasound signals of
the vascular bed. The recent development of site-targeted microbubbles opened up the …

Ultrasound is an important local stimulus for triggering drug release at the target tissue.
Ultrasound-responsive drug delivery systems (URDDS) have become an important research …

Ultrasonication is widely used to exfoliate two dimensional (2D) van der Waals layered
materials such as graphene. Its fundamental mechanism, inertial cavitation, is poorly …